Table 1. Patient characteristics.
| Characteristic | Total n = 83 (%) |
Treatment group | p-value | |||
|---|---|---|---|---|---|---|
| Surgery only n = 32 (38.9%) |
Surgery + radiotherapy n = 16 (19.3%) |
Surgery + chemotherapy n = 12 (14.5%) |
Surgery + chemotherapy + radiotherapy n = 23 (27.7%) |
|||
| Gender | ||||||
| Female | 35 (42.2) | 12 (37.5) | 6 (37.5) | 6 (50) | 11 (47.8) | .799 |
| Male | 48 (57.8) | 20 (62.5) | 10 (62.5) | 6 (50) | 12 (52.2) | |
| Age at diagnosis | ||||||
| ≤60 yrs | 33 (39.8) | 6 (18.75) | 8 (50) | 6 (50) | 13 (56.5) | .016 |
| >60 yrs | 50 (60.2) | 26 (81.25) | 8 (50) | 6 (50) | 10 (43.5) | |
| Histology | ||||||
| SCC | 30 (36.1) | 12 (37.5) | 4 (25) | 4 (33.3) | 10 (43.5) | .707 |
| Other (ADC,…) | 53 (63.9) | 20 (62.5) | 12 (75) | 8 (66.7) | 13 (56.5) | |
| Tumor size | ||||||
| ≤40 | 45 (54.2) | 13 (40.63) | 11 (68.7) | 8 (66.67) | 13 (56.5) | .221 |
| >40 | 38 (45.8) | 19 (59.38) | 5 (31.3) | 4 (33.33) | 10 (43.5) | |
| n of nodal stations involved | ||||||
| ≤1 | 33 (39.8) | 15 (46.9) | 7 (43.7) | 2 (16.7) | 9 (39.1) | .337 |
| >1 | 50 (60.2) | 17 (53.1) | 9 (56.3) | 10 (83.3) | 14 (60.9) | |
| n of positive nodes | ||||||
| ≤1 | 17 (20.5) | 8 (25) | 5 (31.3) | 0 | 4 (17.4) | .172 |
| >1 | 66 (79.5) | 24 (75) | 11 (68.7) | 12 (100) | 19 (82.6) | |
| Surgical margins | ||||||
| Negative | 71 (85.5) | 25 (78.1) | 14 (87.5) | 11 (91.7) | 21 (91.3) | .583 |
| Positive | 12 (14.5) | 7 (21.9) | 2 (12.5) | 1 (8.3) | 2 (8.7) | |
| ECE | ||||||
| Negative | 69 (83.1) | 26 (81.2) | 14 (87.50) | 9 (75.00) | 20 (87) | .566 |
| Positive | 14 (16.9) | 6 (18.8) | 2 (12.50) | 3 (25.00) | 3 (13) | |
Abbreviations: ADC, adenocarcinoma; ECE, extracapsular extension; SCC, squamous cell carcinoma.